| 注册
首页|期刊导航|天津中医药|中医药调控HIF-1α信号通路治疗心肌缺血再灌注损伤的研究进展

中医药调控HIF-1α信号通路治疗心肌缺血再灌注损伤的研究进展

刘祎曼 贾慧雨 冯文帅 郭流漓 江丰 任明

天津中医药2025,Vol.42Issue(4):519-525,7.
天津中医药2025,Vol.42Issue(4):519-525,7.DOI:10.11656/j.issn.1672-1519.2025.04.17

中医药调控HIF-1α信号通路治疗心肌缺血再灌注损伤的研究进展

Research progress of HIF-1α signaling pathway regulated by traditional Chinese medicine in the treatment of myocardial ischemia-reperfusion injury

刘祎曼 1贾慧雨 1冯文帅 1郭流漓 1江丰 1任明2

作者信息

  • 1. 天津中医药大学,天津 301617
  • 2. 天津中医药大学附属保康医院,天津 300073
  • 折叠

摘要

Abstract

Acute myocardial infarction can minimize myocardial ischemic damage and limit the infarct size by thrombolysis,drugs that dilate blood vessels,and percutaneous coronary intervention,but restoration of blood perfusion of ischemic myocardial tissue will lead to myocardial ischemia-reperfusion injury(MIRI).In recent years,it has found that traditional Chinese medicine(TCM)has the unique advantages of multi-component,multi-pathway and multi-target in the treatment of MIRI.Hypoxia-inducible factor 1 alpha(HIF-1α)plays an important role in promoting cell survival and recovery and reducing the degree of myocardial damage by regulating oxidative stress,inflammatory response,angiogenesis,apoptosis and autophagy during MIRI.Therefore,this paper summarized the relationship between HIF-1α signaling pathway and the pathogenesis of MIRI,as well as the current research progress of TCM in regulating HIF-1αsignaling pathway to treat MIRI,in order to provide new ideas for the prevention and treatment of MIRI with TCM.

关键词

HIF-1α信号通路/中医药/心肌缺血再灌注损伤/研究进展

Key words

HIF-1α signaling pathway/traditional Chinese medicine/myocardial ischemia reperfusion injury/research progress

分类

医药卫生

引用本文复制引用

刘祎曼,贾慧雨,冯文帅,郭流漓,江丰,任明..中医药调控HIF-1α信号通路治疗心肌缺血再灌注损伤的研究进展[J].天津中医药,2025,42(4):519-525,7.

基金项目

国家重点研发计划项目(2018YFC1707403). (2018YFC1707403)

天津中医药

1672-1519

访问量0
|
下载量0
段落导航相关论文